About Us

Ethics and Compliance

Overview

At Asahi Kasei Therapeutics, our entire team upholds an unwavering commitment to acting ethically and responsibly in all that we do every day.  As part of living out this commitment, we have established an ethics and compliance program that supports two of our core values: integrity and accountability.  This program ensures we conduct business in compliance with the laws, regulations, guidance, and industry standards that govern our organization. We also carefully consider the impact of each decision on our ability to positively impact health and improve the lives of patients with serious medical conditions.

Our Chief Ethics and Compliance Officer and the Ethics and Compliance Team are responsible for overseeing our ethics and compliance program, which you can access an overview of here.

If you have questions about our ethics and compliance program, please email us at compliance@aktx.com.

Ethics & Compliance Helpline

Asahi Kasei Therapeutics is committed to essential principles of good corporate conduct and integrity across all its activities. If we become aware of violations of law or Company policy, we will investigate the matter and, where appropriate, take disciplinary action and implement corrective measures to prevent future violations.

We have set up an external compliance helpline system called the Asahi Kasei Therapeutics Anonymous Compliance Reporting Helpline—operated by an independent, certified third-party vendor for our employees and related parties to report potential violations of laws or Company guidelines.

To anonymously report a suspected violation of law or Company policy to the Asahi Kasei Therapeutics Anonymous Compliance Reporting Helpline:

Code of Conduct

The Asahi Kasei Therapeutics Code of Conduct has been adopted by the Asahi Kasei Therapeutics Board of Directors to aid its directors, officers, employees, and colleagues with making ethical and legal decisions when conducting business and performing their day-to-day duties.

Access the Asahi Kasei Therapeutics Code of Conduct.

Open Payments/Sunshine Act

We are committed to transparent and accurate reporting under the Open Payments/Sunshine Act, which requires industry-wide reporting of certain payments made to health care providers and teaching hospitals. Examples of payments Asahi Kasei Therapeutics reports under the Open Payments/Sunshine Act include: consulting fees and compensation for services such as speaking engagements; meals, travel, and lodging costs associated with educational programs, advisory boards, or other business meetings; charitable contributions; research funding and grants; and education-related items and other lawful courtesies.

How to Search for Payment Information Using the CMS Open Payments Search Tool

1. Visit the CMS Open Payments searchable database website at https://openpaymentsdata.cms.gov/.
2. Use “Search Open Payments Data” or “Advanced Search” to search by:
   • Reporting manufacturer (e.g., Asahi Kasei Therapeutics formerly Veloxis Pharmaceuticals);
   • Provider or teaching hospital; and/or
   • Geographic location, specialty, or other available filters.
3. Select the Covered Recipient or Manufacturer generated by the search results, which will display, by year, the itemized payment records, including the type of payment or transfer of value, the amount, the date, and the reporting manufacturer.

Additional information about CMS’ Open Payments program can be found at: www.cms.gov/priorities/key-initiatives/open-payments.

For questions regarding Asahi Kasei Therapeutics’ transparency reporting, please contact us at: compliance@aktx.com

California Declaration of Compliance

Please access the Asahi Kasei Therapeutics declaration of compliance with California Health and Safety Code §§ 119400-119402.

State Transparency Requirements

View the latest State Transparency Pricing Sheets here.